Growth Metrics

Concord Medical Services Holdings (CCM) EBITDA Margin: 2009-2016

Historic EBITDA Margin for Concord Medical Services Holdings (CCM) over the last 8 years, with FY2016 value amounting to 67.35%.

  • Concord Medical Services Holdings' EBITDA Margin rose 239600.0% to 1.47% in Q2 2017 from the same period last year, while for Jun 2017 it was 187.79%, marking a year-over-year decrease of 272800.0%. This contributed to the annual value of 67.35% for FY2016, which is 499600.0% down from last year.
  • According to the latest figures from FY2016, Concord Medical Services Holdings' EBITDA Margin is 67.35%, which was down 499600.0% from 17.39% recorded in FY2015.
  • Over the past 5 years, Concord Medical Services Holdings' EBITDA Margin peaked at 29.65% during FY2012, and registered a low of 67.35% during FY2016.
  • Over the past 5 years, Concord Medical Services Holdings' median EBITDA Margin value was 16.49% (recorded in 2013), while the average stood at 3.72%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first skyrocketed by 780300bps in 2012, then crashed by -499600bps in 2016.
  • Concord Medical Services Holdings' EBITDA Margin (Annual) stood at 29.65% in 2012, then crashed by -44bps to 16.49% in 2013, then increased by 21bps to 19.99% in 2014, then crashed by -187bps to 17.39% in 2015, then plummeted by -287bps to 67.35% in 2016.
  • Its EBITDA Margin was 67.35% in FY2016, compared to 17.39% in FY2015 and 19.99% in FY2014.